Morgan Stanley Increases Lam Research (NASDAQ:LRCX) Price Target to $254.00

Lam Research (NASDAQ:LRCX) had its price objective raised by research analysts at Morgan Stanley from $244.00 to $254.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has an “equal weight” rating on the semiconductor company’s stock. Morgan Stanley’s target price suggests a potential upside of 6.25% from the stock’s previous close.

Several other brokerages have also weighed in on LRCX. Stifel Nicolaus increased their target price on Lam Research from $250.00 to $280.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. UBS Group set a $300.00 price objective on Lam Research in a research note on Thursday, January 29th. B. Riley Financial reissued a “buy” rating on shares of Lam Research in a research report on Thursday, January 15th. Barclays set a $250.00 price target on shares of Lam Research in a report on Thursday, January 29th. Finally, Zacks Research raised shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 20th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $245.19.

Lam Research Trading Down 4.2%

Shares of LRCX stock opened at $239.07 on Wednesday. The firm’s 50-day simple moving average is $215.67 and its 200-day simple moving average is $163.89. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. Lam Research has a 1-year low of $56.32 and a 1-year high of $256.68. The firm has a market cap of $298.54 billion, a P/E ratio of 48.99, a PEG ratio of 2.67 and a beta of 1.78.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.17 by $0.10. The firm had revenue of $5.34 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. Lam Research’s revenue for the quarter was up 22.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, equities analysts forecast that Lam Research will post 3.71 EPS for the current year.

Insider Buying and Selling at Lam Research

In other news, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the transaction, the director directly owned 253,705 shares in the company, valued at approximately $57,235,848. This represents a 12.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.31% of the company’s stock.

Hedge Funds Weigh In On Lam Research

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. PMV Capital Advisers LLC acquired a new position in shares of Lam Research in the fourth quarter worth about $25,000. Stance Capital LLC purchased a new stake in Lam Research during the 3rd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new position in shares of Lam Research in the 2nd quarter valued at approximately $27,000. Triumph Capital Management purchased a new position in shares of Lam Research during the 3rd quarter valued at approximately $27,000. Finally, Mcguire Capital Advisors Inc. acquired a new stake in shares of Lam Research during the fourth quarter worth approximately $27,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam announced a technology partnership with CEA-Leti, a management reshuffle, and a new Boise, ID facility aimed at advanced memory manufacturing (near key customer Micron) — moves that strengthen its product roadmap and U.S. footprint for next‑generation and specialty semiconductors. Lam Research Resets Technology Path With CEA Leti Deal And Boise Bet
• Positive Sentiment: Lam has sustained a >$5B quarterly revenue run (Q2 FY26 revenue $5.34B, +22% YoY), reflecting strong demand for wafer‑fab equipment from foundries — a key fundamental tailwind for future earnings. Can Foundry Strength Keep Lam Research’s $5B+ Revenue Streak Alive?
• Positive Sentiment: Morgan Stanley raised its price target on LRCX from $244 to $254 (maintaining an “equal weight” rating), signaling modest analyst conviction in upside versus current levels. Benzinga
• Neutral Sentiment: Lam has become a focus of investor attention (increased search/interest on Zacks), which can amplify intraday moves but doesn’t by itself change fundamentals. Investors Heavily Search Lam Research Corporation (LRCX): Here is What You Need to Know
• Negative Sentiment: Semiconductor stocks sold off in the afternoon on a “buy-the-rumor, sell-the-news” reaction to Nvidia’s earnings/guide — a sector-wide dynamic that pulled down Lam along with peers like Applied Materials and Broadcom. Applied Materials, Broadcom, Lam Research, Western Digital, and Allegro MicroSystems Shares Are Falling, What You Need To Know
• Negative Sentiment: Real-time market coverage noted that LRCX fell more steeply than the broader market today, reflecting short-term selling pressure despite its recent strong results. Lam Research (LRCX) Falls More Steeply Than Broader Market: What Investors Need to Know

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.